STAT+: Will the Treasury restrict U.S. investment in the Chinese biotech sector?
Stat News • 10/22/2026 – 10/23/2026
Summary
The Treasury Department is rumored to propose a rule this week that would restrict U.S. investment in the Chinese biotech sector.
Advertisement
Lindy Score Breakdown (V4.2)
8h
Age
1
Sources
from cluster
8
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier89% (0.5^8/48)
Hero EligibleYes
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: A German biotech has big ambitions in cancer. Now it needs to get a medicine approved
Stat News • 1 day ago
STAT+: GSK picks up hep B drug approval
Stat News • 1 day ago
STAT+: He’s slashing quality at nursing homes. This state is letting it happen
Stat News • 2 days ago
STAT+: Gilead to pay $45 million to settle kickback charges filed by Texas attorney general
Stat News • Today
STAT+: The key health care ballot measures we’re watching in the midterms
Stat News • 2 days ago
STAT+: Roche continues to look to China for new drugs
Stat News • 2 days ago
STAT+: AbbVie skin disorder drug succeeds in late-stage trial, but results miss market expectations
Stat News • Today
STAT+: Crackdowns loom, from China to New York
Stat News • Today
STAT+: What to expect from the Moderna-Merck cancer vaccine data reveal
Stat News • Today
STAT+: Nutrition experts press White House to release ultra-processed food definition
Stat News • Today
